MitraClip implantation is feasible and can effectively reduce mitral regurgitation in patients with a previously implanted MONARC device, despite technical challenges.
Answers are grounded in this paper and cite their sources.
May support MitraClip after prior MONARC despite challenges; hypothesis-generating and requires prospective confirmation before wider use.
Mitral regurgitation is associated with a worsened prognosis in dilated cardiomyopathy. First standard therapy consists of a mitral valve reconstruction through heart surgery including the heart–lung machine. In patients with high comorbidity, catheter-based techniques have been developed. In the Evolution I study, the MONARC system was implanted in the coronary sinus in the functional mitral regurgitation. A reduction in regurgitation by >1 grade was documented in 50% of the patients. MitraClip is an alternative, edge-to-edge technique, which joined the posterior and anterior leaflet by implanting a clip. It can be used for both functional and degenerative mitral regurgitations. We reported a case of MitraClip procedure with the use of two clips and a reduction of mitral regurgitation to grade 0–1 after implanting a MONARC device four years ago with missing relevant reduction in mitral regurgitation. With this report, we illustrated the management of Mitraclip in a patient with an implanted MONARC device and technical difficulties through the bowing of the posterior annulus.
No takes yet. Share an insight, caveat, or question.
Rutschow et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: